BIMATOPROST Labatec gtt opht 0.3 mg/ml fl 3 ml

7680683910013 CH-68391 S01EE03
BIMATOPROST Labatec gtt opht 0.3 mg/ml fl 3 ml
BIMATOPROST Labatec gtt opht 0.3 mg/ml fl 3 ml
BIMATOPROST Labatec gtt opht 0.3 mg/ml fl 3 ml
1 / 3
google

Details

Product number
-
CPT
-
Packaging group
-
Unit
-

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
09/08/2023
Patient information leaflet
Français
09/08/2023
Patient information leaflet
Italien
09/08/2023
Professional SmPC
Allemand
09/08/2023
Professional SmPC
Français
09/08/2023

Detailed composition

Substance Quantity Type Category
(N/A)
0.3 MG Substance Wirkstoff (Principe actif)
(N/A)
0.05 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HBESI
(N/A)
0.95 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Authorization holder

Labatec Pharma SA

1217 Meyrin

Authorization information

Swissmedic authorization number
68391
Drug name
Bimatoprost Labatec 0.3 mg/ml, collyre en solution
Galenic form
AUL
ATC Code
S01EE03
Authorization status
Z
Dispensation category
B
First authorization
22/04/2022
Authorization expiration date
21/04/2027
IT number
11.09.0.
Domain
Human medicine

Packaging details

Description (FR)
BIMATOPROST Labatec gtt opht 0.3 mg/ml fl 3 ml
Description (DE)
BIMATOPROST Labatec Gtt Opht 0.3 mg/ml Fl 3 ml
Market launch
22/04/2022
Narcotic (BTM)
No